Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mesothelioma | 110 | 2024 | 806 | 16.310 |
Why?
|
Pleural Neoplasms | 87 | 2024 | 609 | 15.240 |
Why?
|
Lung Neoplasms | 114 | 2024 | 13238 | 4.700 |
Why?
|
Pneumonectomy | 45 | 2024 | 1109 | 3.430 |
Why?
|
Esophagectomy | 15 | 2023 | 468 | 1.810 |
Why?
|
Thoracic Surgical Procedures | 9 | 2024 | 347 | 1.750 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 35 | 2024 | 5247 | 1.400 |
Why?
|
Gene Expression Profiling | 24 | 2020 | 9374 | 1.240 |
Why?
|
Esophageal Neoplasms | 16 | 2023 | 1655 | 1.220 |
Why?
|
Solitary Pulmonary Nodule | 5 | 2020 | 267 | 1.220 |
Why?
|
Thoracic Surgery, Video-Assisted | 6 | 2020 | 277 | 1.190 |
Why?
|
Neoplasm Staging | 46 | 2024 | 11123 | 1.150 |
Why?
|
Neoadjuvant Therapy | 19 | 2023 | 2809 | 1.020 |
Why?
|
Fundoplication | 3 | 2014 | 145 | 1.010 |
Why?
|
Pericardial Effusion | 3 | 2018 | 247 | 0.860 |
Why?
|
Empyema | 1 | 2021 | 41 | 0.790 |
Why?
|
CA-125 Antigen | 1 | 2024 | 280 | 0.780 |
Why?
|
Molecular Diagnostic Techniques | 5 | 2015 | 611 | 0.730 |
Why?
|
Cisplatin | 15 | 2023 | 1642 | 0.710 |
Why?
|
Inhibitor of Apoptosis Proteins | 4 | 2016 | 197 | 0.710 |
Why?
|
Adenocarcinoma | 19 | 2023 | 6311 | 0.690 |
Why?
|
Asbestos | 7 | 2022 | 251 | 0.680 |
Why?
|
Gene Expression Regulation, Neoplastic | 22 | 2021 | 8491 | 0.660 |
Why?
|
Anastomotic Leak | 1 | 2020 | 164 | 0.640 |
Why?
|
Neoplasm Proteins | 10 | 2014 | 3613 | 0.630 |
Why?
|
Humans | 266 | 2024 | 759255 | 0.610 |
Why?
|
Gastroesophageal Reflux | 3 | 2014 | 817 | 0.590 |
Why?
|
Chemotherapy, Adjuvant | 13 | 2021 | 3519 | 0.590 |
Why?
|
Prognosis | 39 | 2021 | 29561 | 0.580 |
Why?
|
Gene Expression | 12 | 2020 | 7593 | 0.580 |
Why?
|
Aged | 119 | 2024 | 168617 | 0.580 |
Why?
|
Pericardium | 4 | 2018 | 675 | 0.540 |
Why?
|
Combined Modality Therapy | 21 | 2020 | 8549 | 0.530 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 11 | 2023 | 3207 | 0.500 |
Why?
|
Spheroids, Cellular | 8 | 2019 | 329 | 0.500 |
Why?
|
Neoplasm Recurrence, Local | 13 | 2024 | 9269 | 0.490 |
Why?
|
Heart Neoplasms | 1 | 2018 | 360 | 0.480 |
Why?
|
Esophagus | 2 | 2020 | 1023 | 0.480 |
Why?
|
Middle Aged | 119 | 2024 | 219653 | 0.480 |
Why?
|
Biopsy | 7 | 2019 | 6772 | 0.470 |
Why?
|
Antineoplastic Agents | 22 | 2021 | 13621 | 0.470 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2015 | 238 | 0.450 |
Why?
|
Radiotherapy | 3 | 2019 | 1503 | 0.450 |
Why?
|
Male | 135 | 2024 | 358719 | 0.450 |
Why?
|
Ubiquitin Thiolesterase | 9 | 2022 | 453 | 0.430 |
Why?
|
Postoperative Complications | 22 | 2023 | 15672 | 0.430 |
Why?
|
Lung | 18 | 2023 | 9982 | 0.430 |
Why?
|
Aged, 80 and over | 49 | 2024 | 58867 | 0.420 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2015 | 164 | 0.420 |
Why?
|
Oligonucleotide Array Sequence Analysis | 14 | 2014 | 3774 | 0.420 |
Why?
|
Tomography, X-Ray Computed | 14 | 2020 | 20461 | 0.420 |
Why?
|
Autophagy | 5 | 2019 | 1336 | 0.420 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2024 | 2774 | 0.410 |
Why?
|
Female | 130 | 2024 | 390240 | 0.410 |
Why?
|
Cell Line, Tumor | 31 | 2023 | 16871 | 0.400 |
Why?
|
Treatment Outcome | 38 | 2024 | 64879 | 0.390 |
Why?
|
Pleura | 6 | 2019 | 243 | 0.390 |
Why?
|
Lung Diseases | 5 | 2014 | 1915 | 0.380 |
Why?
|
Thoracic Neoplasms | 5 | 2019 | 266 | 0.380 |
Why?
|
Alternative Splicing | 4 | 2016 | 1091 | 0.370 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 11 | 2014 | 4573 | 0.360 |
Why?
|
Pyrazines | 4 | 2021 | 1201 | 0.360 |
Why?
|
Lymph Nodes | 5 | 2020 | 3489 | 0.360 |
Why?
|
Biopsy, Fine-Needle | 3 | 2016 | 1111 | 0.360 |
Why?
|
Venous Thrombosis | 1 | 2020 | 1293 | 0.350 |
Why?
|
Retrospective Studies | 51 | 2024 | 80121 | 0.350 |
Why?
|
Carcinoma, Squamous Cell | 7 | 2020 | 4025 | 0.340 |
Why?
|
RNA, Neoplasm | 6 | 2010 | 748 | 0.340 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2016 | 1765 | 0.340 |
Why?
|
Adult | 88 | 2024 | 219390 | 0.330 |
Why?
|
Kaplan-Meier Estimate | 12 | 2021 | 6532 | 0.330 |
Why?
|
Thoracoscopy | 4 | 2004 | 176 | 0.320 |
Why?
|
Esophageal Achalasia | 1 | 2010 | 95 | 0.320 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2018 | 1588 | 0.320 |
Why?
|
Neoplasm Invasiveness | 7 | 2024 | 3619 | 0.310 |
Why?
|
Predictive Value of Tests | 13 | 2024 | 15264 | 0.310 |
Why?
|
Tissue Fixation | 3 | 2016 | 241 | 0.310 |
Why?
|
Hyperthermia, Induced | 5 | 2020 | 414 | 0.300 |
Why?
|
Chylothorax | 1 | 2008 | 83 | 0.300 |
Why?
|
Postoperative Care | 3 | 2014 | 1478 | 0.300 |
Why?
|
Bronchi | 3 | 2020 | 846 | 0.300 |
Why?
|
Tumor Suppressor Proteins | 9 | 2022 | 2804 | 0.290 |
Why?
|
GPI-Linked Proteins | 2 | 2024 | 468 | 0.290 |
Why?
|
Embolism, Air | 1 | 2008 | 110 | 0.290 |
Why?
|
Mediastinal Neoplasms | 2 | 2007 | 401 | 0.290 |
Why?
|
Surgery, Computer-Assisted | 1 | 2015 | 1008 | 0.290 |
Why?
|
Surgical Instruments | 1 | 2010 | 386 | 0.280 |
Why?
|
Pulmonary Surgical Procedures | 1 | 2007 | 30 | 0.280 |
Why?
|
Thoracic Surgery | 2 | 2024 | 722 | 0.280 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1849 | 0.280 |
Why?
|
Peritoneal Neoplasms | 3 | 2020 | 706 | 0.280 |
Why?
|
Lasers, Gas | 1 | 2008 | 94 | 0.270 |
Why?
|
Survival Rate | 24 | 2021 | 12800 | 0.270 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2008 | 203 | 0.270 |
Why?
|
Pulmonary Embolism | 1 | 2020 | 2536 | 0.270 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2013 | 1093 | 0.270 |
Why?
|
Formaldehyde | 3 | 2016 | 358 | 0.260 |
Why?
|
Laparoscopy | 2 | 2010 | 2157 | 0.260 |
Why?
|
Paraganglioma | 1 | 2007 | 142 | 0.260 |
Why?
|
Survival Analysis | 18 | 2018 | 10185 | 0.260 |
Why?
|
Total Quality Management | 1 | 2007 | 264 | 0.260 |
Why?
|
Diagnosis, Differential | 12 | 2024 | 12964 | 0.250 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2008 | 329 | 0.250 |
Why?
|
Immunohistochemistry | 13 | 2022 | 11058 | 0.240 |
Why?
|
Cell Survival | 7 | 2016 | 5796 | 0.240 |
Why?
|
Bronchoscopy | 3 | 2008 | 902 | 0.240 |
Why?
|
Paraffin Embedding | 2 | 2016 | 302 | 0.240 |
Why?
|
Intraoperative Care | 3 | 2015 | 768 | 0.240 |
Why?
|
Tumor Microenvironment | 4 | 2024 | 3810 | 0.240 |
Why?
|
Single-Cell Analysis | 4 | 2024 | 2347 | 0.240 |
Why?
|
RNA, Messenger | 12 | 2020 | 12774 | 0.230 |
Why?
|
Boronic Acids | 2 | 2012 | 914 | 0.230 |
Why?
|
Proportional Hazards Models | 13 | 2021 | 12522 | 0.230 |
Why?
|
Pericardiectomy | 2 | 2018 | 46 | 0.230 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 12 | 2022 | 11653 | 0.230 |
Why?
|
Sensitivity and Specificity | 7 | 2024 | 14652 | 0.230 |
Why?
|
Genes, Tumor Suppressor | 2 | 2005 | 1056 | 0.230 |
Why?
|
Smoking Cessation | 3 | 2011 | 2059 | 0.230 |
Why?
|
Mutation | 15 | 2024 | 29877 | 0.220 |
Why?
|
Reproducibility of Results | 10 | 2024 | 20031 | 0.220 |
Why?
|
Burns, Inhalation | 1 | 2003 | 35 | 0.220 |
Why?
|
Adaptor Proteins, Signal Transducing | 7 | 2019 | 2896 | 0.220 |
Why?
|
Neurofibromin 2 | 3 | 2022 | 270 | 0.210 |
Why?
|
DNA Methylation | 9 | 2018 | 4371 | 0.210 |
Why?
|
Prospective Studies | 14 | 2024 | 54204 | 0.210 |
Why?
|
Disease-Free Survival | 8 | 2022 | 6813 | 0.200 |
Why?
|
Genome, Human | 2 | 2018 | 4412 | 0.200 |
Why?
|
United States Department of Veterans Affairs | 1 | 2007 | 910 | 0.200 |
Why?
|
Lung Transplantation | 3 | 2009 | 1301 | 0.200 |
Why?
|
Granuloma, Foreign-Body | 1 | 2021 | 42 | 0.190 |
Why?
|
Deoxycytidine | 3 | 2018 | 860 | 0.190 |
Why?
|
Trachea | 2 | 2008 | 1082 | 0.190 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2002 | 257 | 0.190 |
Why?
|
National Cancer Institute (U.S.) | 5 | 2020 | 295 | 0.190 |
Why?
|
Waiting Lists | 1 | 2006 | 750 | 0.190 |
Why?
|
Genetic Predisposition to Disease | 9 | 2022 | 17750 | 0.190 |
Why?
|
Thymoma | 1 | 2022 | 187 | 0.190 |
Why?
|
Reoperation | 6 | 2018 | 4287 | 0.190 |
Why?
|
Genomics | 6 | 2022 | 5775 | 0.190 |
Why?
|
Follow-Up Studies | 17 | 2020 | 39216 | 0.180 |
Why?
|
Laser Therapy | 1 | 2008 | 1093 | 0.180 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2021 | 174 | 0.180 |
Why?
|
Keratins | 1 | 2021 | 497 | 0.180 |
Why?
|
Biopsy, Needle | 4 | 2018 | 1633 | 0.180 |
Why?
|
Thymus Neoplasms | 1 | 2022 | 274 | 0.170 |
Why?
|
Esophageal Stenosis | 1 | 2001 | 194 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-met | 3 | 2014 | 567 | 0.170 |
Why?
|
Solitary Fibrous Tumor, Pleural | 1 | 2019 | 25 | 0.170 |
Why?
|
Chromosome Aberrations | 3 | 2014 | 1771 | 0.170 |
Why?
|
Acute Kidney Injury | 2 | 2023 | 1935 | 0.170 |
Why?
|
Carcinoid Tumor | 2 | 2014 | 228 | 0.170 |
Why?
|
Oncogenes | 1 | 2005 | 1221 | 0.170 |
Why?
|
Aorta | 1 | 2007 | 2042 | 0.170 |
Why?
|
Lymphatic Metastasis | 7 | 2021 | 2943 | 0.170 |
Why?
|
Tumor Cells, Cultured | 8 | 2020 | 6131 | 0.160 |
Why?
|
Aniline Compounds | 2 | 2021 | 1058 | 0.160 |
Why?
|
Peritoneum | 1 | 2020 | 225 | 0.160 |
Why?
|
Sequence Analysis, DNA | 1 | 2010 | 4716 | 0.160 |
Why?
|
Sarcoma, Synovial | 1 | 2000 | 151 | 0.160 |
Why?
|
Deglutition | 1 | 2020 | 208 | 0.160 |
Why?
|
Cell Culture Techniques | 4 | 2019 | 1666 | 0.160 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2020 | 3615 | 0.160 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 7460 | 0.160 |
Why?
|
CpG Islands | 5 | 2011 | 1221 | 0.160 |
Why?
|
Stromal Cells | 1 | 2024 | 1327 | 0.160 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2020 | 327 | 0.160 |
Why?
|
Risk Assessment | 10 | 2021 | 24049 | 0.150 |
Why?
|
Up-Regulation | 3 | 2021 | 4132 | 0.150 |
Why?
|
Genome-Wide Association Study | 4 | 2018 | 12580 | 0.150 |
Why?
|
Gastrectomy | 2 | 2021 | 668 | 0.150 |
Why?
|
HMGB1 Protein | 1 | 2019 | 138 | 0.150 |
Why?
|
Heart Arrest | 1 | 2008 | 1503 | 0.150 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2011 | 1614 | 0.150 |
Why?
|
Risk Factors | 16 | 2022 | 74167 | 0.150 |
Why?
|
Time Factors | 14 | 2021 | 40109 | 0.150 |
Why?
|
Young Adult | 16 | 2020 | 58483 | 0.140 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2020 | 629 | 0.140 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2022 | 2925 | 0.140 |
Why?
|
Glutamate-Ammonia Ligase | 3 | 1987 | 72 | 0.140 |
Why?
|
Receptors, Cell Surface | 3 | 2006 | 2822 | 0.140 |
Why?
|
Thrombocytosis | 1 | 2017 | 82 | 0.140 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 2 | 2007 | 60 | 0.140 |
Why?
|
Gastric Bypass | 1 | 2005 | 819 | 0.140 |
Why?
|
Radiotherapy, Adjuvant | 8 | 2015 | 1788 | 0.140 |
Why?
|
Hydroxamic Acids | 2 | 2012 | 482 | 0.140 |
Why?
|
Cytomegalovirus | 1 | 2021 | 757 | 0.140 |
Why?
|
Specialties, Surgical | 1 | 2021 | 389 | 0.140 |
Why?
|
Body Mass Index | 1 | 2014 | 12874 | 0.140 |
Why?
|
Pulmonary Artery | 3 | 2014 | 1910 | 0.140 |
Why?
|
Argininosuccinate Synthase | 1 | 2016 | 15 | 0.140 |
Why?
|
Expert Testimony | 1 | 2019 | 362 | 0.140 |
Why?
|
Cell Nucleus | 3 | 2020 | 2911 | 0.140 |
Why?
|
Ribonucleoprotein, U2 Small Nuclear | 1 | 2016 | 21 | 0.140 |
Why?
|
Thoracotomy | 1 | 2018 | 362 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 5 | 2021 | 4491 | 0.130 |
Why?
|
Cohort Studies | 13 | 2023 | 41247 | 0.130 |
Why?
|
Apoptosis | 11 | 2023 | 9492 | 0.130 |
Why?
|
Smoking | 5 | 2023 | 9066 | 0.130 |
Why?
|
Cell Proliferation | 10 | 2020 | 10440 | 0.130 |
Why?
|
UDPglucose-Hexose-1-Phosphate Uridylyltransferase | 2 | 1985 | 4 | 0.130 |
Why?
|
Testicular Neoplasms | 1 | 2022 | 800 | 0.130 |
Why?
|
Multivariate Analysis | 6 | 2016 | 12152 | 0.130 |
Why?
|
Paraneoplastic Syndromes | 1 | 2017 | 155 | 0.130 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2021 | 1708 | 0.130 |
Why?
|
Benzimidazoles | 1 | 2021 | 858 | 0.130 |
Why?
|
Expressed Sequence Tags | 2 | 2021 | 250 | 0.130 |
Why?
|
Sulfonamides | 3 | 2021 | 1972 | 0.130 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2016 | 113 | 0.130 |
Why?
|
Bronchial Diseases | 1 | 1996 | 151 | 0.130 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4360 | 0.130 |
Why?
|
Medical Oncology | 3 | 2020 | 2311 | 0.130 |
Why?
|
Neutrophils | 2 | 2019 | 3767 | 0.130 |
Why?
|
Microtubule-Associated Proteins | 3 | 2019 | 1078 | 0.120 |
Why?
|
DNA Mutational Analysis | 4 | 2020 | 4111 | 0.120 |
Why?
|
Surgical Procedures, Operative | 1 | 2007 | 1914 | 0.120 |
Why?
|
Sp1 Transcription Factor | 1 | 2015 | 140 | 0.120 |
Why?
|
Computational Biology | 4 | 2020 | 3505 | 0.120 |
Why?
|
Epigenesis, Genetic | 6 | 2020 | 3754 | 0.120 |
Why?
|
Immunophenotyping | 2 | 2017 | 1870 | 0.120 |
Why?
|
Cell Lineage | 1 | 2024 | 2524 | 0.120 |
Why?
|
Cell Cycle | 5 | 2014 | 2939 | 0.120 |
Why?
|
DNA, Neoplasm | 3 | 2010 | 1744 | 0.120 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2017 | 346 | 0.120 |
Why?
|
Cluster Analysis | 4 | 2023 | 2698 | 0.120 |
Why?
|
Obesity, Morbid | 1 | 2005 | 1277 | 0.120 |
Why?
|
DNA, Viral | 1 | 2021 | 2195 | 0.120 |
Why?
|
DNA, Mitochondrial | 2 | 2024 | 849 | 0.120 |
Why?
|
Adolescent | 18 | 2020 | 87560 | 0.120 |
Why?
|
Hematopoiesis | 1 | 2024 | 2063 | 0.120 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2191 | 0.120 |
Why?
|
Flow Cytometry | 3 | 2017 | 5870 | 0.120 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2016 | 321 | 0.120 |
Why?
|
Telomerase | 2 | 2012 | 747 | 0.120 |
Why?
|
Boston | 5 | 2020 | 9274 | 0.110 |
Why?
|
Esophageal Fistula | 2 | 2006 | 60 | 0.110 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2017 | 5214 | 0.110 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2017 | 556 | 0.110 |
Why?
|
Point Mutation | 2 | 2010 | 1594 | 0.110 |
Why?
|
Gene Dosage | 3 | 2013 | 1218 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2023 | 1408 | 0.110 |
Why?
|
Hydroxychloroquine | 1 | 2017 | 428 | 0.110 |
Why?
|
Gene Silencing | 4 | 2010 | 1512 | 0.110 |
Why?
|
Activin Receptors, Type I | 2 | 2018 | 136 | 0.110 |
Why?
|
Antibiotic Prophylaxis | 2 | 2013 | 640 | 0.110 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2198 | 0.110 |
Why?
|
Nucleotidyltransferases | 2 | 1985 | 243 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2021 | 3584 | 0.110 |
Why?
|
Thoracostomy | 1 | 2013 | 73 | 0.110 |
Why?
|
Diagnostic Imaging | 2 | 2019 | 3526 | 0.110 |
Why?
|
Incidence | 8 | 2020 | 21336 | 0.110 |
Why?
|
Guanine | 3 | 2012 | 278 | 0.100 |
Why?
|
Neoplasms | 7 | 2020 | 22019 | 0.100 |
Why?
|
Cefazolin | 1 | 2013 | 93 | 0.100 |
Why?
|
Glutamates | 3 | 2012 | 391 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1790 | 0.100 |
Why?
|
Chest Tubes | 1 | 2013 | 146 | 0.100 |
Why?
|
Immunotherapy, Adoptive | 1 | 2022 | 1442 | 0.100 |
Why?
|
Transcription, Genetic | 8 | 2024 | 7595 | 0.100 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2019 | 698 | 0.100 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2017 | 709 | 0.100 |
Why?
|
Odds Ratio | 3 | 2020 | 9711 | 0.100 |
Why?
|
Heparin | 1 | 2020 | 1656 | 0.100 |
Why?
|
Cardiopulmonary Bypass | 3 | 2008 | 1097 | 0.100 |
Why?
|
Military Personnel | 1 | 2021 | 1239 | 0.100 |
Why?
|
Translocation, Genetic | 1 | 2018 | 1388 | 0.100 |
Why?
|
Obesity | 1 | 2014 | 12896 | 0.100 |
Why?
|
DNA-Binding Proteins | 6 | 2020 | 9590 | 0.100 |
Why?
|
Preoperative Period | 1 | 2014 | 555 | 0.100 |
Why?
|
Carcinoma in Situ | 1 | 2017 | 796 | 0.100 |
Why?
|
Sequence Analysis, RNA | 3 | 2020 | 1993 | 0.100 |
Why?
|
Interleukin-4 Receptor alpha Subunit | 1 | 2012 | 57 | 0.100 |
Why?
|
Molecular Typing | 1 | 2012 | 116 | 0.100 |
Why?
|
Proteome | 1 | 2021 | 1849 | 0.100 |
Why?
|
Algorithms | 3 | 2021 | 13946 | 0.100 |
Why?
|
Carcinogens | 1 | 2013 | 449 | 0.100 |
Why?
|
Endoscopy | 1 | 2001 | 1840 | 0.100 |
Why?
|
Case-Control Studies | 5 | 2021 | 21988 | 0.090 |
Why?
|
Hematopoietic Stem Cells | 1 | 2024 | 3390 | 0.090 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2016 | 1173 | 0.090 |
Why?
|
Coronary Aneurysm | 1 | 2014 | 233 | 0.090 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2018 | 1030 | 0.090 |
Why?
|
Membrane Proteins | 3 | 2022 | 7851 | 0.090 |
Why?
|
Protein Isoforms | 1 | 2016 | 1695 | 0.090 |
Why?
|
Interleukin-17 | 1 | 2017 | 908 | 0.090 |
Why?
|
Adaptive Immunity | 1 | 2016 | 724 | 0.090 |
Why?
|
Surgical Wound Infection | 2 | 2013 | 1529 | 0.090 |
Why?
|
Phosphoproteins | 3 | 2016 | 2441 | 0.090 |
Why?
|
Thoracic Vertebrae | 1 | 2015 | 597 | 0.090 |
Why?
|
Gene Expression Regulation | 6 | 2018 | 11908 | 0.090 |
Why?
|
Confidence Intervals | 2 | 2014 | 2932 | 0.090 |
Why?
|
Molecular Targeted Therapy | 3 | 2021 | 2803 | 0.090 |
Why?
|
Saphenous Vein | 1 | 2014 | 538 | 0.090 |
Why?
|
Bone Neoplasms | 2 | 2014 | 2532 | 0.090 |
Why?
|
United States | 14 | 2024 | 72237 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2015 | 2061 | 0.090 |
Why?
|
Epithelial Cells | 2 | 2021 | 3664 | 0.090 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2012 | 97 | 0.090 |
Why?
|
Precancerous Conditions | 3 | 2017 | 979 | 0.090 |
Why?
|
Gastroscopes | 1 | 2010 | 19 | 0.090 |
Why?
|
Mice | 16 | 2021 | 81138 | 0.090 |
Why?
|
Hospital Mortality | 2 | 2014 | 5414 | 0.090 |
Why?
|
Analysis of Variance | 5 | 2013 | 6242 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3143 | 0.090 |
Why?
|
Iron Regulatory Protein 2 | 1 | 2009 | 42 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2019 | 8055 | 0.090 |
Why?
|
Sex Factors | 4 | 2023 | 10518 | 0.090 |
Why?
|
Receptors, Growth Factor | 1 | 2011 | 326 | 0.090 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2010 | 228 | 0.090 |
Why?
|
Preoperative Care | 3 | 2014 | 2256 | 0.090 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2003 | 886 | 0.080 |
Why?
|
Transcription Factors | 5 | 2020 | 12106 | 0.080 |
Why?
|
Animals | 23 | 2021 | 167838 | 0.080 |
Why?
|
Monocytes | 1 | 2019 | 2575 | 0.080 |
Why?
|
Drug Resistance, Multiple | 2 | 2008 | 254 | 0.080 |
Why?
|
T-Lymphocytes | 2 | 2017 | 10181 | 0.080 |
Why?
|
Immunoglobulin G | 1 | 2021 | 4546 | 0.080 |
Why?
|
PII Nitrogen Regulatory Proteins | 2 | 1985 | 6 | 0.080 |
Why?
|
Databases, Genetic | 2 | 2009 | 1740 | 0.080 |
Why?
|
Amifostine | 1 | 2009 | 40 | 0.080 |
Why?
|
Tumor Burden | 3 | 2021 | 1886 | 0.080 |
Why?
|
Neovascularization, Pathologic | 1 | 2019 | 2635 | 0.080 |
Why?
|
Treatment Failure | 4 | 2015 | 2642 | 0.080 |
Why?
|
INDEL Mutation | 1 | 2010 | 265 | 0.080 |
Why?
|
Forced Expiratory Volume | 2 | 2023 | 1807 | 0.080 |
Why?
|
Signal Transduction | 8 | 2024 | 23362 | 0.080 |
Why?
|
Vinblastine | 1 | 2010 | 487 | 0.080 |
Why?
|
Gastrostomy | 2 | 2001 | 322 | 0.080 |
Why?
|
Radiation-Protective Agents | 1 | 2009 | 88 | 0.080 |
Why?
|
Recurrence | 3 | 2014 | 8469 | 0.080 |
Why?
|
Spinal Neoplasms | 1 | 2015 | 716 | 0.080 |
Why?
|
Heart-Lung Transplantation | 1 | 2009 | 87 | 0.080 |
Why?
|
Esophagogastric Junction | 3 | 2016 | 343 | 0.080 |
Why?
|
RNA Precursors | 1 | 2009 | 212 | 0.080 |
Why?
|
Societies, Medical | 1 | 2020 | 3890 | 0.080 |
Why?
|
Antigens, Surface | 2 | 2011 | 1616 | 0.080 |
Why?
|
Cytoprotection | 1 | 2009 | 200 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2018 | 15750 | 0.080 |
Why?
|
Genes, Neoplasm | 1 | 2010 | 370 | 0.080 |
Why?
|
Karyotyping | 1 | 2010 | 1177 | 0.080 |
Why?
|
Paxillin | 1 | 2008 | 86 | 0.080 |
Why?
|
Head and Neck Neoplasms | 3 | 2011 | 2876 | 0.080 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2011 | 423 | 0.070 |
Why?
|
Radiography, Interventional | 1 | 2015 | 1113 | 0.070 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2010 | 717 | 0.070 |
Why?
|
Dendritic Cells | 1 | 2019 | 2725 | 0.070 |
Why?
|
Breast Neoplasms | 2 | 2013 | 21022 | 0.070 |
Why?
|
Genes, Intracisternal A-Particle | 1 | 2007 | 4 | 0.070 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2018 | 2499 | 0.070 |
Why?
|
Body Burden | 1 | 2008 | 158 | 0.070 |
Why?
|
Proteins | 2 | 2002 | 6029 | 0.070 |
Why?
|
Carrier Proteins | 1 | 2001 | 4939 | 0.070 |
Why?
|
Melanoma | 3 | 2022 | 5692 | 0.070 |
Why?
|
Genetic Loci | 1 | 2017 | 2617 | 0.070 |
Why?
|
Antigens, Nuclear | 1 | 2008 | 184 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2017 | 2867 | 0.070 |
Why?
|
Leiomyosarcoma | 1 | 2011 | 424 | 0.070 |
Why?
|
Collagen Type IV | 2 | 2005 | 127 | 0.070 |
Why?
|
Pyruvate Kinase | 1 | 2009 | 190 | 0.070 |
Why?
|
Sequence Deletion | 2 | 2010 | 1494 | 0.070 |
Why?
|
Immune Tolerance | 1 | 2016 | 2298 | 0.070 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1293 | 0.070 |
Why?
|
Microarray Analysis | 2 | 2008 | 748 | 0.070 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2012 | 1135 | 0.070 |
Why?
|
Esophageal Perforation | 1 | 2007 | 65 | 0.070 |
Why?
|
Frozen Sections | 1 | 2007 | 153 | 0.070 |
Why?
|
Intubation | 1 | 2007 | 139 | 0.070 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5497 | 0.070 |
Why?
|
RNA Editing | 1 | 2008 | 152 | 0.070 |
Why?
|
Myocardium | 2 | 2018 | 4680 | 0.070 |
Why?
|
Bronchiolitis Obliterans | 2 | 2006 | 211 | 0.070 |
Why?
|
Reference Standards | 1 | 2010 | 1002 | 0.070 |
Why?
|
Down-Regulation | 1 | 2013 | 2920 | 0.070 |
Why?
|
Blotting, Western | 3 | 2013 | 5039 | 0.070 |
Why?
|
Mucocele | 1 | 2006 | 51 | 0.070 |
Why?
|
Patient Selection | 4 | 2015 | 4269 | 0.070 |
Why?
|
Myeloid Cells | 1 | 2011 | 818 | 0.070 |
Why?
|
Pyrimidines | 2 | 2015 | 2996 | 0.070 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2013 | 1376 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 3 | 2017 | 5635 | 0.070 |
Why?
|
Macrophages | 2 | 2019 | 5730 | 0.070 |
Why?
|
Mice, SCID | 2 | 2021 | 2628 | 0.070 |
Why?
|
Early Detection of Cancer | 2 | 2022 | 3204 | 0.070 |
Why?
|
Hodgkin Disease | 1 | 2013 | 1381 | 0.060 |
Why?
|
Cancer Vaccines | 2 | 2003 | 1044 | 0.060 |
Why?
|
Radiation Pneumonitis | 1 | 2006 | 103 | 0.060 |
Why?
|
Operon | 2 | 1985 | 369 | 0.060 |
Why?
|
Aneurysm | 1 | 2008 | 337 | 0.060 |
Why?
|
Life Style | 1 | 2017 | 3886 | 0.060 |
Why?
|
Contrast Media | 5 | 2020 | 5302 | 0.060 |
Why?
|
Esophageal Diseases | 1 | 2006 | 168 | 0.060 |
Why?
|
Orthopedic Procedures | 1 | 2015 | 1262 | 0.060 |
Why?
|
Magnetic Resonance Angiography | 1 | 2012 | 1429 | 0.060 |
Why?
|
Mice, Nude | 3 | 2020 | 3605 | 0.060 |
Why?
|
Sheep | 1 | 2008 | 1441 | 0.060 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2020 | 679 | 0.060 |
Why?
|
Gene Rearrangement | 1 | 2010 | 1122 | 0.060 |
Why?
|
Cardia | 1 | 2004 | 59 | 0.060 |
Why?
|
Promoter Regions, Genetic | 4 | 2011 | 5789 | 0.060 |
Why?
|
Phosphorylation | 7 | 2014 | 8313 | 0.060 |
Why?
|
Escherichia coli | 3 | 1987 | 4222 | 0.060 |
Why?
|
Lymph Node Excision | 2 | 2020 | 1304 | 0.060 |
Why?
|
Prostatic Neoplasms | 2 | 2007 | 11324 | 0.060 |
Why?
|
Hepatocyte Growth Factor | 1 | 2006 | 266 | 0.060 |
Why?
|
Coronary Artery Bypass | 1 | 2014 | 2274 | 0.060 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2011 | 937 | 0.060 |
Why?
|
Equipment Design | 2 | 2010 | 3529 | 0.060 |
Why?
|
Chromosome Mapping | 2 | 2010 | 4625 | 0.060 |
Why?
|
Hemangioendothelioma | 1 | 2004 | 111 | 0.060 |
Why?
|
Demography | 1 | 2009 | 1648 | 0.060 |
Why?
|
Anticoagulants | 1 | 2020 | 4897 | 0.060 |
Why?
|
Respiratory Function Tests | 2 | 2006 | 1685 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2017 | 5793 | 0.060 |
Why?
|
Video-Assisted Surgery | 1 | 2004 | 51 | 0.060 |
Why?
|
Hemodynamics | 1 | 2014 | 4164 | 0.060 |
Why?
|
Brain Neoplasms | 1 | 2005 | 8953 | 0.060 |
Why?
|
Software | 1 | 2017 | 4421 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2021 | 3207 | 0.050 |
Why?
|
Patient Preference | 1 | 2011 | 919 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 3152 | 0.050 |
Why?
|
Vascular Fistula | 1 | 2003 | 50 | 0.050 |
Why?
|
MicroRNAs | 3 | 2014 | 3797 | 0.050 |
Why?
|
Tissue Array Analysis | 2 | 2016 | 551 | 0.050 |
Why?
|
Europe | 2 | 2020 | 3429 | 0.050 |
Why?
|
Severity of Illness Index | 3 | 2017 | 15815 | 0.050 |
Why?
|
Bronchial Fistula | 1 | 2003 | 83 | 0.050 |
Why?
|
Neoplasms, Mesothelial | 1 | 2002 | 3 | 0.050 |
Why?
|
Airway Obstruction | 1 | 2008 | 659 | 0.050 |
Why?
|
Disease Progression | 6 | 2017 | 13479 | 0.050 |
Why?
|
Feasibility Studies | 4 | 2017 | 5194 | 0.050 |
Why?
|
Soft Tissue Neoplasms | 1 | 2011 | 1151 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5796 | 0.050 |
Why?
|
Germ-Line Mutation | 2 | 2022 | 1843 | 0.050 |
Why?
|
Oligodeoxyribonucleotides, Antisense | 1 | 2002 | 58 | 0.050 |
Why?
|
Gene Knockdown Techniques | 2 | 2021 | 1619 | 0.050 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2004 | 265 | 0.050 |
Why?
|
Discriminant Analysis | 1 | 2002 | 223 | 0.050 |
Why?
|
Uterine Neoplasms | 1 | 2011 | 1442 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 2 | 2014 | 4040 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2015 | 2448 | 0.050 |
Why?
|
Organ Specificity | 2 | 2009 | 1953 | 0.050 |
Why?
|
Thymectomy | 1 | 2022 | 194 | 0.050 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2007 | 1345 | 0.050 |
Why?
|
Pulmonary Fibrosis | 1 | 2006 | 507 | 0.050 |
Why?
|
Bradycardia | 1 | 2023 | 298 | 0.050 |
Why?
|
Bacterial Proteins | 2 | 1985 | 3824 | 0.050 |
Why?
|
Digestive System Surgical Procedures | 1 | 2007 | 577 | 0.050 |
Why?
|
Blotting, Southern | 1 | 2002 | 779 | 0.050 |
Why?
|
Jejunostomy | 1 | 2001 | 59 | 0.050 |
Why?
|
bcl-X Protein | 1 | 2023 | 413 | 0.050 |
Why?
|
Receptor, IGF Type 1 | 2 | 1994 | 380 | 0.050 |
Why?
|
Folate Receptors, GPI-Anchored | 1 | 2001 | 23 | 0.050 |
Why?
|
Israel | 1 | 2023 | 721 | 0.050 |
Why?
|
Oceans and Seas | 1 | 2021 | 48 | 0.050 |
Why?
|
Camptothecin | 2 | 2016 | 588 | 0.050 |
Why?
|
Protein Kinases | 1 | 2008 | 1612 | 0.050 |
Why?
|
Cell Movement | 5 | 2014 | 5209 | 0.050 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2006 | 1109 | 0.050 |
Why?
|
Age Factors | 5 | 2017 | 18394 | 0.050 |
Why?
|
Histone Deacetylases | 1 | 2005 | 718 | 0.050 |
Why?
|
RNA Interference | 3 | 2019 | 2847 | 0.050 |
Why?
|
Genetic Testing | 1 | 2014 | 3531 | 0.050 |
Why?
|
Exercise Tolerance | 1 | 2006 | 815 | 0.050 |
Why?
|
Repressor Proteins | 1 | 2011 | 2981 | 0.050 |
Why?
|
Gastrointestinal Diseases | 1 | 2009 | 1190 | 0.040 |
Why?
|
Loss of Heterozygosity | 1 | 2003 | 659 | 0.040 |
Why?
|
Aging | 3 | 2024 | 8634 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2015 | 2866 | 0.040 |
Why?
|
Intensive Care Units | 1 | 2013 | 3731 | 0.040 |
Why?
|
Mitochondrial Membranes | 1 | 2021 | 171 | 0.040 |
Why?
|
Clone Cells | 1 | 2024 | 1663 | 0.040 |
Why?
|
COS Cells | 1 | 2002 | 1129 | 0.040 |
Why?
|
Aortic Valve Insufficiency | 1 | 2004 | 584 | 0.040 |
Why?
|
Dilatation | 1 | 2001 | 303 | 0.040 |
Why?
|
Magnesium | 1 | 2023 | 810 | 0.040 |
Why?
|
Environmental Exposure | 3 | 2009 | 4389 | 0.040 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2006 | 801 | 0.040 |
Why?
|
Therapeutic Irrigation | 2 | 2012 | 293 | 0.040 |
Why?
|
Quantitative Trait Loci | 2 | 2018 | 2083 | 0.040 |
Why?
|
Stomach Neoplasms | 2 | 2013 | 1422 | 0.040 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2019 | 44 | 0.040 |
Why?
|
Drug Synergism | 2 | 2014 | 1755 | 0.040 |
Why?
|
Databases, Factual | 3 | 2015 | 8000 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 2013 | 1705 | 0.040 |
Why?
|
Freezing | 1 | 2020 | 306 | 0.040 |
Why?
|
Consensus | 2 | 2019 | 3095 | 0.040 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2020 | 286 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10333 | 0.040 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2017 | 1085 | 0.040 |
Why?
|
Superior Vena Cava Syndrome | 1 | 1999 | 57 | 0.040 |
Why?
|
Radiotherapy Dosage | 3 | 2015 | 2895 | 0.040 |
Why?
|
Sarcoidosis | 1 | 2004 | 520 | 0.040 |
Why?
|
Foundations | 1 | 2019 | 97 | 0.040 |
Why?
|
Protein Methyltransferases | 1 | 2018 | 54 | 0.040 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2005 | 2416 | 0.040 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2008 | 1425 | 0.040 |
Why?
|
Pyrimidinones | 1 | 2021 | 383 | 0.040 |
Why?
|
Escherichia coli Proteins | 1 | 1985 | 1066 | 0.040 |
Why?
|
International Agencies | 1 | 2019 | 244 | 0.040 |
Why?
|
Heart Aneurysm | 1 | 1998 | 115 | 0.040 |
Why?
|
Vascular Surgical Procedures | 1 | 2007 | 1471 | 0.040 |
Why?
|
Calreticulin | 1 | 2019 | 115 | 0.040 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2018 | 31 | 0.040 |
Why?
|
NF-kappa B | 1 | 2007 | 2486 | 0.040 |
Why?
|
Colon | 1 | 2006 | 1791 | 0.040 |
Why?
|
In Situ Hybridization | 1 | 2002 | 1900 | 0.040 |
Why?
|
Reference Values | 2 | 2002 | 4918 | 0.040 |
Why?
|
Mediastinoscopy | 1 | 1997 | 29 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 52 | 0.040 |
Why?
|
Disease Management | 2 | 2005 | 2498 | 0.040 |
Why?
|
Radiation-Sensitizing Agents | 1 | 1999 | 345 | 0.040 |
Why?
|
Cytomegalovirus Infections | 2 | 2021 | 832 | 0.040 |
Why?
|
Barrett Esophagus | 1 | 2001 | 490 | 0.040 |
Why?
|
Constriction, Pathologic | 2 | 2002 | 1101 | 0.040 |
Why?
|
Respiratory Tract Diseases | 1 | 2003 | 747 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2004 | 2824 | 0.040 |
Why?
|
Enzyme Activation | 3 | 2011 | 3604 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2001 | 944 | 0.040 |
Why?
|
Drug Combinations | 1 | 2023 | 2023 | 0.040 |
Why?
|
Mastectomy, Segmental | 1 | 2022 | 965 | 0.040 |
Why?
|
Cell Communication | 1 | 2024 | 1641 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 192 | 0.030 |
Why?
|
Base Sequence | 5 | 2019 | 12450 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2016 | 4898 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2021 | 9528 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1836 | 0.030 |
Why?
|
Carboplatin | 1 | 1999 | 789 | 0.030 |
Why?
|
Phenotype | 5 | 2019 | 16532 | 0.030 |
Why?
|
Vault Ribonucleoprotein Particles | 1 | 2016 | 11 | 0.030 |
Why?
|
Cell Adhesion | 3 | 2011 | 3094 | 0.030 |
Why?
|
Annexin A4 | 1 | 2016 | 9 | 0.030 |
Why?
|
Ultrasonography | 2 | 2008 | 5955 | 0.030 |
Why?
|
Inhalation Exposure | 1 | 2019 | 429 | 0.030 |
Why?
|
Suppression, Genetic | 2 | 1987 | 190 | 0.030 |
Why?
|
Motion | 1 | 2020 | 778 | 0.030 |
Why?
|
Connective Tissue Growth Factor | 1 | 2016 | 91 | 0.030 |
Why?
|
Aneurysm, False | 1 | 1998 | 258 | 0.030 |
Why?
|
Plicamycin | 1 | 2015 | 12 | 0.030 |
Why?
|
Methods | 1 | 1996 | 1075 | 0.030 |
Why?
|
Length of Stay | 4 | 2020 | 6452 | 0.030 |
Why?
|
Bronchial Neoplasms | 1 | 1996 | 110 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2021 | 1007 | 0.030 |
Why?
|
Anorexia | 1 | 2016 | 154 | 0.030 |
Why?
|
Uncertainty | 1 | 2021 | 754 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2020 | 729 | 0.030 |
Why?
|
Menopause | 1 | 2003 | 1640 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 10827 | 0.030 |
Why?
|
Gene Deletion | 2 | 2019 | 2667 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2022 | 1265 | 0.030 |
Why?
|
Australia | 1 | 2019 | 1287 | 0.030 |
Why?
|
Tobacco Use Disorder | 2 | 2011 | 699 | 0.030 |
Why?
|
RNA, Small Interfering | 3 | 2011 | 3443 | 0.030 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2015 | 88 | 0.030 |
Why?
|
Tubulin | 1 | 2019 | 692 | 0.030 |
Why?
|
Maximum Tolerated Dose | 2 | 2009 | 876 | 0.030 |
Why?
|
Pilot Projects | 2 | 2023 | 8540 | 0.030 |
Why?
|
DNA | 3 | 2006 | 7237 | 0.030 |
Why?
|
Registries | 3 | 2018 | 8434 | 0.030 |
Why?
|
Focal Adhesion Kinase 1 | 2 | 2005 | 119 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 7380 | 0.030 |
Why?
|
Platelet Count | 1 | 2017 | 776 | 0.030 |
Why?
|
Water | 1 | 2021 | 1401 | 0.030 |
Why?
|
Electrocardiography | 1 | 2008 | 6400 | 0.030 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 2 | 2005 | 186 | 0.030 |
Why?
|
RNA-Binding Proteins | 2 | 2018 | 1902 | 0.030 |
Why?
|
Pyrrolidinones | 1 | 2014 | 116 | 0.030 |
Why?
|
Genes, Regulator | 2 | 1985 | 374 | 0.030 |
Why?
|
Positron-Emission Tomography | 2 | 2023 | 6436 | 0.030 |
Why?
|
Respiration | 1 | 2020 | 1648 | 0.030 |
Why?
|
Nausea | 1 | 2016 | 675 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1558 | 0.030 |
Why?
|
Genes, Bacterial | 3 | 1987 | 1070 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 1994 | 0.030 |
Why?
|
International Cooperation | 1 | 2019 | 1436 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36160 | 0.030 |
Why?
|
Receptors, Virus | 1 | 2016 | 639 | 0.030 |
Why?
|
Video Recording | 1 | 1997 | 954 | 0.030 |
Why?
|
Epigenomics | 1 | 2018 | 935 | 0.030 |
Why?
|
Paclitaxel | 1 | 1999 | 1715 | 0.030 |
Why?
|
Chromatin | 1 | 2024 | 2939 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1266 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2020 | 14381 | 0.020 |
Why?
|
Meglumine | 1 | 2012 | 145 | 0.020 |
Why?
|
Guanine Nucleotide Dissociation Inhibitors | 1 | 2011 | 23 | 0.020 |
Why?
|
Asbestosis | 1 | 2011 | 81 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2019 | 2651 | 0.020 |
Why?
|
Artifacts | 1 | 2020 | 1893 | 0.020 |
Why?
|
Pulmonary Circulation | 1 | 2014 | 743 | 0.020 |
Why?
|
Pulmonary Edema | 1 | 2014 | 409 | 0.020 |
Why?
|
Risk | 1 | 2003 | 9623 | 0.020 |
Why?
|
Iohexol | 1 | 2012 | 198 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2017 | 809 | 0.020 |
Why?
|
Cotinine | 1 | 2011 | 203 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2015 | 657 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2020 | 1889 | 0.020 |
Why?
|
Pyrazoles | 1 | 2021 | 1989 | 0.020 |
Why?
|
Deglutition Disorders | 1 | 2016 | 629 | 0.020 |
Why?
|
Neoplasm Metastasis | 3 | 2009 | 4883 | 0.020 |
Why?
|
Benzoquinones | 1 | 2011 | 198 | 0.020 |
Why?
|
Indoles | 2 | 2011 | 1828 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2018 | 3161 | 0.020 |
Why?
|
Food, Formulated | 1 | 1990 | 102 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2388 | 0.020 |
Why?
|
Sex Distribution | 2 | 2005 | 2294 | 0.020 |
Why?
|
Heart | 1 | 2002 | 4390 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 2014 | 881 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 2 | 1994 | 1919 | 0.020 |
Why?
|
Parenteral Nutrition, Total | 1 | 1990 | 303 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3603 | 0.020 |
Why?
|
Histidine Ammonia-Lyase | 2 | 1985 | 9 | 0.020 |
Why?
|
Lactams, Macrocyclic | 1 | 2011 | 315 | 0.020 |
Why?
|
Quinolines | 1 | 2014 | 758 | 0.020 |
Why?
|
Defibrillators, Implantable | 1 | 1998 | 1490 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2011 | 859 | 0.020 |
Why?
|
Radiography | 2 | 2014 | 6964 | 0.020 |
Why?
|
Occupational Exposure | 1 | 2019 | 1806 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 2012 | 826 | 0.020 |
Why?
|
Age Distribution | 2 | 2005 | 2892 | 0.020 |
Why?
|
Muscles | 1 | 1993 | 1582 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2014 | 1114 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2008 | 18110 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 13284 | 0.020 |
Why?
|
Imidazoles | 1 | 2014 | 1175 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 2012 | 660 | 0.020 |
Why?
|
Carbon Monoxide | 1 | 2011 | 541 | 0.020 |
Why?
|
Chromones | 1 | 2008 | 150 | 0.020 |
Why?
|
Exons | 2 | 2010 | 2389 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4046 | 0.020 |
Why?
|
Cytosine | 1 | 2009 | 213 | 0.020 |
Why?
|
Sulfones | 1 | 2011 | 447 | 0.020 |
Why?
|
Pancreatic Diseases | 1 | 1990 | 344 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3600 | 0.020 |
Why?
|
Cycloheximide | 1 | 2008 | 343 | 0.020 |
Why?
|
Interleukin-4 | 1 | 2012 | 1132 | 0.020 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2008 | 203 | 0.020 |
Why?
|
RNA | 2 | 2008 | 2723 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2009 | 516 | 0.020 |
Why?
|
Sternum | 1 | 2008 | 175 | 0.020 |
Why?
|
Cell Line | 2 | 2016 | 15636 | 0.020 |
Why?
|
Barium | 1 | 2007 | 62 | 0.020 |
Why?
|
Glutamine | 1 | 1990 | 576 | 0.020 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 192 | 0.020 |
Why?
|
tau Proteins | 1 | 2018 | 2081 | 0.020 |
Why?
|
Genes, erbB-1 | 1 | 2008 | 160 | 0.020 |
Why?
|
Digital Rectal Examination | 1 | 2007 | 40 | 0.020 |
Why?
|
Hypertension | 1 | 2007 | 8594 | 0.020 |
Why?
|
Nitrogen | 2 | 1990 | 351 | 0.020 |
Why?
|
Protease Nexins | 1 | 2006 | 39 | 0.020 |
Why?
|
Adenosine | 1 | 2011 | 832 | 0.020 |
Why?
|
Graft Rejection | 1 | 2000 | 4418 | 0.020 |
Why?
|
Cell Death | 1 | 2012 | 1669 | 0.020 |
Why?
|
Sigma Factor | 1 | 1987 | 174 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 25860 | 0.020 |
Why?
|
Tyrosine | 2 | 2005 | 1440 | 0.020 |
Why?
|
Drug Interactions | 1 | 2011 | 1424 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4622 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2011 | 1342 | 0.020 |
Why?
|
Mitosis | 1 | 2011 | 1195 | 0.020 |
Why?
|
Health Planning Guidelines | 1 | 2006 | 151 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2018 | 3694 | 0.020 |
Why?
|
Cytochalasin D | 1 | 2005 | 91 | 0.020 |
Why?
|
Gelsolin | 1 | 2006 | 189 | 0.020 |
Why?
|
Hernia, Hiatal | 1 | 2006 | 90 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2008 | 1766 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2006 | 384 | 0.020 |
Why?
|
Morpholines | 1 | 2008 | 582 | 0.020 |
Why?
|
Safety | 2 | 1999 | 1149 | 0.020 |
Why?
|
Vanadates | 1 | 2004 | 82 | 0.020 |
Why?
|
Enzyme Inhibitors | 2 | 2006 | 3724 | 0.020 |
Why?
|
Molecular Sequence Data | 4 | 2006 | 17629 | 0.020 |
Why?
|
Medicare | 1 | 2023 | 6763 | 0.010 |
Why?
|
Culture Media, Serum-Free | 1 | 2004 | 151 | 0.010 |
Why?
|
Family Health | 1 | 2009 | 1258 | 0.010 |
Why?
|
Chromosomes, Bacterial | 1 | 1985 | 280 | 0.010 |
Why?
|
Genistein | 1 | 2004 | 86 | 0.010 |
Why?
|
RNA, Complementary | 1 | 2004 | 45 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 474 | 0.010 |
Why?
|
Pathology, Molecular | 1 | 2007 | 330 | 0.010 |
Why?
|
Naphthalenes | 1 | 2005 | 198 | 0.010 |
Why?
|
Quinazolines | 1 | 2011 | 1362 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 478 | 0.010 |
Why?
|
Microscopy, Video | 1 | 2004 | 242 | 0.010 |
Why?
|
Cyclin D1 | 1 | 2006 | 453 | 0.010 |
Why?
|
Pseudopodia | 1 | 2004 | 168 | 0.010 |
Why?
|
Hospitals, Community | 1 | 2006 | 367 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1655 | 0.010 |
Why?
|
Pancreas | 1 | 1990 | 1677 | 0.010 |
Why?
|
Wound Healing | 1 | 2014 | 2782 | 0.010 |
Why?
|
Hypertension, Pulmonary | 1 | 2014 | 1567 | 0.010 |
Why?
|
Vena Cava, Superior | 1 | 2004 | 197 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 2006 | 1030 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 2006 | 695 | 0.010 |
Why?
|
Hot Temperature | 1 | 2009 | 1434 | 0.010 |
Why?
|
Counseling | 1 | 2011 | 1550 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2016 | 4545 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7346 | 0.010 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2002 | 84 | 0.010 |
Why?
|
Cell Division | 2 | 2004 | 4463 | 0.010 |
Why?
|
Cell Size | 1 | 2004 | 623 | 0.010 |
Why?
|
Hypersensitivity, Delayed | 1 | 2003 | 490 | 0.010 |
Why?
|
Regression Analysis | 1 | 2012 | 6359 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 1985 | 752 | 0.010 |
Why?
|
Protein Subunits | 1 | 2005 | 943 | 0.010 |
Why?
|
Klebsiella pneumoniae | 1 | 1983 | 255 | 0.010 |
Why?
|
Models, Biological | 2 | 2010 | 9466 | 0.010 |
Why?
|
Macromolecular Substances | 2 | 1994 | 1432 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8609 | 0.010 |
Why?
|
Sirolimus | 1 | 2008 | 1548 | 0.010 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2006 | 772 | 0.010 |
Why?
|
Vena Cava, Inferior | 1 | 2004 | 458 | 0.010 |
Why?
|
Transfection | 2 | 2002 | 5783 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 21981 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2011 | 2309 | 0.010 |
Why?
|
Mediastinum | 1 | 2001 | 265 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2003 | 787 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2005 | 1201 | 0.010 |
Why?
|
Child | 2 | 2020 | 79623 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2005 | 1247 | 0.010 |
Why?
|
Cytoskeleton | 1 | 2005 | 1167 | 0.010 |
Why?
|
SEER Program | 1 | 2005 | 1531 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2004 | 6070 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2852 | 0.010 |
Why?
|
Premenopause | 1 | 2003 | 1039 | 0.010 |
Why?
|
Models, Genetic | 1 | 2009 | 3443 | 0.010 |
Why?
|
Carcinoma, Small Cell | 1 | 2001 | 416 | 0.010 |
Why?
|
Adenoviridae | 1 | 2003 | 1084 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2012 | 3333 | 0.010 |
Why?
|
Alleles | 1 | 2010 | 6897 | 0.010 |
Why?
|
Brachytherapy | 1 | 2006 | 1239 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2005 | 3468 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2013 | 12386 | 0.010 |
Why?
|
History, 20th Century | 1 | 2007 | 2777 | 0.010 |
Why?
|
Probability | 1 | 2004 | 2475 | 0.010 |
Why?
|
Health Promotion | 1 | 2011 | 2204 | 0.010 |
Why?
|
Retinoblastoma Protein | 1 | 2002 | 671 | 0.010 |
Why?
|
Massachusetts | 1 | 2011 | 8788 | 0.010 |
Why?
|
Radiotherapy, High-Energy | 1 | 1999 | 228 | 0.010 |
Why?
|
Cause of Death | 1 | 2009 | 3721 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2003 | 2120 | 0.010 |
Why?
|
DNA Primers | 1 | 2002 | 2817 | 0.010 |
Why?
|
Databases as Topic | 1 | 1999 | 474 | 0.010 |
Why?
|
Surgical Staplers | 1 | 1997 | 34 | 0.010 |
Why?
|
Genetic Engineering | 1 | 2003 | 932 | 0.010 |
Why?
|
Respiratory Insufficiency | 1 | 2006 | 1225 | 0.010 |
Why?
|
Hemoptysis | 1 | 1998 | 152 | 0.010 |
Why?
|
Esophagoscopy | 1 | 1999 | 393 | 0.010 |
Why?
|
Amino Acid Sequence | 3 | 1994 | 13456 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2006 | 2415 | 0.010 |
Why?
|
Lung Volume Measurements | 1 | 1997 | 376 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2004 | 1972 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 3804 | 0.010 |
Why?
|
Kinetics | 2 | 1994 | 6380 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2011 | 18968 | 0.010 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2001 | 493 | 0.010 |
Why?
|
Fiber Optic Technology | 1 | 1997 | 291 | 0.010 |
Why?
|
Abdomen | 1 | 2001 | 1121 | 0.010 |
Why?
|
Phylogeny | 1 | 2003 | 2765 | 0.010 |
Why?
|
Histones | 1 | 2006 | 2582 | 0.010 |
Why?
|
Piperazines | 1 | 2006 | 2517 | 0.010 |
Why?
|
Fibroblasts | 1 | 2005 | 4084 | 0.010 |
Why?
|
Electrodes, Implanted | 1 | 1998 | 832 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2006 | 2277 | 0.010 |
Why?
|
Kidney | 1 | 2009 | 7066 | 0.010 |
Why?
|
Child, Preschool | 1 | 1996 | 41935 | 0.010 |
Why?
|
Peptide Mapping | 1 | 1993 | 262 | 0.010 |
Why?
|
Phosphotyrosine | 1 | 1994 | 456 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 1993 | 421 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1994 | 1143 | 0.010 |
Why?
|
Receptors, Somatomedin | 1 | 1992 | 56 | 0.010 |
Why?
|
Phosphopeptides | 1 | 1993 | 241 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1994 | 777 | 0.010 |
Why?
|
Inflammation | 1 | 2012 | 10747 | 0.010 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 1994 | 557 | 0.010 |
Why?
|
Muscle Development | 1 | 1993 | 261 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1992 | 852 | 0.010 |
Why?
|
Molecular Weight | 1 | 1993 | 2186 | 0.010 |
Why?
|
CHO Cells | 1 | 1994 | 1389 | 0.010 |
Why?
|
Stents | 1 | 2003 | 3308 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1992 | 1055 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1994 | 1694 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1994 | 1993 | 0.010 |
Why?
|
Trypsinogen | 1 | 1990 | 84 | 0.010 |
Why?
|
Cricetinae | 1 | 1994 | 2427 | 0.010 |
Why?
|
Genotype | 1 | 1985 | 12940 | 0.010 |
Why?
|
Sarcoma | 1 | 2001 | 1786 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 1746 | 0.010 |
Why?
|
Carcinoma | 1 | 2001 | 2334 | 0.010 |
Why?
|
Internet | 1 | 2001 | 3073 | 0.010 |
Why?
|
Introns | 1 | 1992 | 976 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2009 | 26109 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1990 | 2094 | 0.010 |
Why?
|
Models, Statistical | 1 | 2003 | 5066 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1994 | 4171 | 0.000 |
Why?
|
Lipase | 1 | 1990 | 324 | 0.000 |
Why?
|
RNA Splicing | 1 | 1992 | 915 | 0.000 |
Why?
|
Immunosuppressive Agents | 1 | 2000 | 4168 | 0.000 |
Why?
|
Genetic Variation | 1 | 2001 | 6531 | 0.000 |
Why?
|
Rats | 2 | 1993 | 23694 | 0.000 |
Why?
|
Cell Differentiation | 1 | 2003 | 11476 | 0.000 |
Why?
|
Culture Media | 1 | 1987 | 899 | 0.000 |
Why?
|
Antibodies | 1 | 1993 | 2423 | 0.000 |
Why?
|
Atrophy | 1 | 1990 | 1625 | 0.000 |
Why?
|
Organ Size | 1 | 1990 | 2248 | 0.000 |
Why?
|
Glutamate Dehydrogenase | 1 | 1983 | 50 | 0.000 |
Why?
|
Ammonia | 1 | 1983 | 236 | 0.000 |
Why?
|
DNA, Bacterial | 1 | 1987 | 1454 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1993 | 8157 | 0.000 |
Why?
|
Peptides | 1 | 1993 | 4357 | 0.000 |
Why?
|
Body Weight | 1 | 1990 | 4608 | 0.000 |
Why?
|
Intestinal Mucosa | 1 | 1990 | 3021 | 0.000 |
Why?
|
Pregnancy | 1 | 1993 | 29658 | 0.000 |
Why?
|